In the present study, we aimed to quantify the circulating levels of novel serum biomarkers including GDF-15, PIVKA-II, sdLDL, suPAR, and of CRP in hospitalized COVID-19 patients compared with healthy subjects and to evaluate their association(s) with outcomes in COVID-19. The gene discussed is CRP; the disease is COVID-19.